Atlas Trials

Effect of Neflamapimod on Brain Inflammation in Alzheimer's Disease Patients

Clinical trial NCT03435861 · COMPLETED

Trial details

NCT number
NCT03435861
Sponsor
University Hospital, Toulouse
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Alzheimer Disease
Start date
2018-10-08
Primary completion
2021-04-30
Enrollment
34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.